The thesis
Channel-pullback is a disciplined "buy the dip, but only in a confirmed uptrend" strategy. It waits for price to pull back toward the lower regression channel or a volume-support level inside an established uptrend, enters there, and exits at the upper channel or overhead resistance. The idea is to buy strength on temporary weakness rather than chase breakouts. Its universe is a conservative basket of 24 US large-caps spanning tech (AAPL, MSFT, NVDA, GOOGL), financials (JPM, BAC, V, MA), healthcare (JNJ, UNH, PFE, ABBV), staples (PG, KO, WMT, COST) and energy (XOM, CVX).
Recent activity
The live book has been active but patient. Over the last two weeks it logged scheduled runs on 3–10 November, with two of those sessions (3 and 6 November) executing zero trades — a sign it is willing to sit on its hands when no clean setup appears. When it does act, it round-trips a small cluster of names: AAPL and MSFT have been bought and sold repeatedly (e.g. buying AAPL at $346.49 and MSFT at $538.81 on 5 November, selling MSFT at $546.96 on 9 November), alongside energy entries in XOM (11 shares at $168.81) and CVX (9 shares at $216.40) on 4 November.
The equity curve has drifted lower recently, slipping from a total of $10,033.31 on 4 November to $9,883.98 on 10 November — currently a touch underwater against its starting stake. Holdings and cash swing meaningfully run-to-run (cash ranged from roughly $2,823 to $6,674), consistent with a strategy that cycles capital in and out quickly.
Backtest and validation
Over 451 days the backtest returned 7.62% (final equity $10,761.52, ~4.19% CAGR). The character is telling: a 39.39% win rate across 137 trades means losers outnumber winners, so the positive return depends on winners being larger than losers. Risk-adjusted performance is modest — a Sharpe of 0.40 and a 14.83% max drawdown — and turnover is a hefty 2,311%, though fees stayed low at $137 total with no FX cost.
Crucially, the strategy failed its validation gate. Three of four walk-forward folds were positive, with fold 3 outstanding (+20.68%, Sharpe 3.86). But fold 2 was ugly: −11.42% with a −1.70 Sharpe and a 16.09% drawdown. Out-of-sample return averaged 3.63% (OOS Sharpe 0.74). The decisive numbers are the probabilistic ones: across 7 trials, the deflated Sharpe ratio came in at just 0.196 — below the threshold that would signal the edge is unlikely to be luck.
Verdict
Channel-pullback has a coherent, well-scoped thesis and a believable trade pattern, and three of four folds suggest a real edge in trending regimes. But the honest read is cautious: the low deflated Sharpe, the single brutal fold, and a sub-40% hit rate mean it is regime-dependent and vulnerable when uptrends break. It earns its place as a live experiment to watch — not yet a validated workhorse.